Oluwole Osungunna Michael
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Afr J Infect Dis. 2022 Aug 17;16(2 Suppl):59-71. doi: 10.21010/Ajid.v16i2S.7. eCollection 2022.
Biofilm formation, especially on indwelling medical devices such as catheters, can result in infections and substantially affect patients' quality of life. Biofilm-associated infections have led to increased morbidity and mortality, increased cost of treatment, and length of hospital stay. However, all of the identified consequences of the biofilm-associated infections had been attributed to the reduced susceptibility of biofilm to conventional antimicrobial agents which has necessitated the development of a new strategy for biofilm infections control, thereby making a search for more effective antimicrobial agents from plant source inevitable. So far, some antimicrobial agents (crude or isolated compounds) from plant sources affect a specific stage of biofilm development while a few of them have been developed into a suitable dosage form for biofilm control. In this review, an attempt is made to look into some definitions of biofilm by "biofilmologists", stages in biofilm formation, mechanisms of resistance in biofilm, biofilm control strategies, the use of some natural products in biofilm control and concepts of probiotics as agents of biofilm control.
生物膜的形成,尤其是在诸如导管等植入式医疗设备上形成生物膜,可导致感染并严重影响患者的生活质量。与生物膜相关的感染已导致发病率和死亡率上升、治疗成本增加以及住院时间延长。然而,生物膜相关感染的所有已确定后果都归因于生物膜对传统抗菌药物的敏感性降低,这就需要制定一种控制生物膜感染的新策略,从而不可避免地要从植物来源寻找更有效的抗菌药物。到目前为止,一些来自植物来源的抗菌剂(粗提物或分离出的化合物)会影响生物膜形成的特定阶段,其中少数已被开发成用于控制生物膜的合适剂型。在本综述中,我们试图探讨“生物膜学家”对生物膜的一些定义、生物膜形成的阶段、生物膜中的耐药机制、生物膜控制策略、一些天然产物在生物膜控制中的应用以及益生菌作为生物膜控制剂的概念。